Imaging in metastatic breast cancer, CT, PET/CT, MRI, WB-DWI, CCA: review and new perspectives
D Lother, M Robert, E Elwood, S Smith, N Tunariu… - Cancer Imaging, 2023 - Springer
Background Breast cancer is the most frequent cancer in women and remains the second
leading cause of death in Western countries. It represents a heterogeneous group of …
leading cause of death in Western countries. It represents a heterogeneous group of …
[HTML][HTML] MRI-based contrast clearance analysis shows high differentiation accuracy between radiation-induced reactions and progressive disease after cranial …
R Bodensohn, R Forbrig, S Quach, J Reis… - ESMO open, 2022 - Elsevier
Background Pseudoprogression (PsP) or radiation necrosis (RN) may frequently occur after
cranial radiotherapy and show a similar imaging pattern compared with progressive disease …
cranial radiotherapy and show a similar imaging pattern compared with progressive disease …
Contrast Clearance Analysis (CCA) to Assess Viable Tumour following Stereotactic Radiosurgery (SRS) to Brain Metastasis in Non-Small Cell Lung Cancer (NSCLC)
S Mohamedkhan, S Hindocha, J de Boisanger… - Cancers, 2024 - mdpi.com
Simple Summary Brain metastases are common in lung cancer and increasingly treated
using targeted stereotactic radiosurgery (SRS). Post-SRS changes (including radionecrosis) …
using targeted stereotactic radiosurgery (SRS). Post-SRS changes (including radionecrosis) …
[HTML][HTML] Diagnostic accuracy of MRI techniques for treatment response evaluation in patients with brain metastasis: A systematic review and meta-analysis
WHT Teunissen, CW Govaerts, MCA Kramer… - Radiotherapy and …, 2022 - Elsevier
Background Treatment response assessment in patients with brain metastasis uses contrast
enhanced T1-weighted MRI. Advanced MRI techniques have been studied, but the …
enhanced T1-weighted MRI. Advanced MRI techniques have been studied, but the …
Comparison of a new MR rapid wash-out map with MR perfusion in brain tumors
E Khadhraoui, L Schmidt, S Klebingat, R Schwab… - BMC cancer, 2024 - Springer
Background MR perfusion is a standard marker to distinguish progression and therapy-
associated changes after surgery and radiochemotherapy for glioblastoma. TRAMs …
associated changes after surgery and radiochemotherapy for glioblastoma. TRAMs …
MRI Treatment Response Assessment Maps (TRAMs) for differentiating recurrent glioblastoma from radiation necrosis
SJ Müller, E Khadhraoui, O Ganslandt… - Journal of Neuro …, 2024 - Springer
Background MRI treatment response assessment maps (TRAMs) were introduced to
distinguish recurrent malignant glioma from therapy related changes. TRAMs are calculated …
distinguish recurrent malignant glioma from therapy related changes. TRAMs are calculated …
Efficacy of hypofractionated Gamma Knife radiosurgery in treating surgical beds of metastatic brain tumors
Y Samanci, MA Tepebasili, GD Ardor… - Journal of Clinical …, 2024 - Elsevier
Objective Surgery alone for metastatic brain tumors (METs) often results in local recurrence
due to microscopic residual tumor tissue. While stereotactic radiosurgery (SRS) is commonly …
due to microscopic residual tumor tissue. While stereotactic radiosurgery (SRS) is commonly …
Investigating the role of delayed contrast magnetic resonance imaging (MRI) to differentiate radiation necrosis from tumour recurrence in brain metastases after …
L Admojo, J Korte, N Anderson… - Journal of Medical …, 2023 - Wiley Online Library
Introduction The incidence of radionecrosis (RN) after stereotactic radiosurgery (SRS) to
brain metastases is increasing. An overlap in the conventional MRI appearances of RN and …
brain metastases is increasing. An overlap in the conventional MRI appearances of RN and …
Role of postoperative imaging in neuro-oncology
Postoperative imaging in primary and secondary brain tumors is becoming challenging due
to advancements in molecular genetic classification of brain tumors influencing advancing …
to advancements in molecular genetic classification of brain tumors influencing advancing …
[PDF][PDF] RESPONSE ASSESSMENT OF GBM AFTER RADIO-CHEMOTHERAPY AND DURING IMMUNOTHERAPY BY DELAYED CONTRAST TRAMS (TREATMENT …
D Aquino, F Savoldi, Y Mardor, D Last… - Immuno-Radiotherapy for … - boa.unimib.it
Glioblastoma (GBM) is the most frequent malignant primary brain tumor. It mainly affects
adults and carries a poor prognosis [1]. The current standard of care (SOC) therapy consists …
adults and carries a poor prognosis [1]. The current standard of care (SOC) therapy consists …